- Report
- May 2024
- 134 Pages
Global
From €5977EUR$6,499USD£5,056GBP
- Report
- June 2023
- 118 Pages
Global
From €4139EUR$4,500USD£3,501GBP
- Report
- December 2021
- 99 Pages
Global
From €4139EUR$4,500USD£3,501GBP
- Report
- November 2021
- 109 Pages
Global
From €4139EUR$4,500USD£3,501GBP
- Report
- April 2018
Global
From €4139EUR$4,500USD£3,501GBP
- Report
- April 2024
- 121 Pages
Global
From €3633EUR$3,950USD£3,073GBP
- Report
- January 2024
- 143 Pages
Global
From €3909EUR$4,250USD£3,306GBP
- Report
- December 2022
- 142 Pages
Global
From €4093EUR$4,450USD£3,462GBP
- Report
- July 2024
- 80 Pages
Japan
From €3219EUR$3,500USD£2,723GBP
- Report
- April 2024
- 180 Pages
Global
From €4139EUR$4,500USD£3,501GBP
- Report
- April 2024
- 180 Pages
Global
From €4139EUR$4,500USD£3,501GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1839EUR$2,000USD£1,556GBP
- Report
- March 2024
- 30 Pages
Global
From €2989EUR$3,250USD£2,528GBP
- Report
- February 2024
- 30 Pages
Global
From €2989EUR$3,250USD£2,528GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4553EUR$4,950USD£3,851GBP
- Report
- January 2024
- 175 Pages
Global
From €8737EUR$9,500USD£7,391GBP
- Report
- November 2023
- 30 Pages
Global
From €2989EUR$3,250USD£2,528GBP
- Report
- November 2023
- 30 Pages
Global
From €2989EUR$3,250USD£2,528GBP
- Report
- November 2023
- 115 Pages
United States
From €3449EUR$3,750USD£2,917GBP
- Report
- August 2023
- 147 Pages
Global
From €4369EUR$4,750USD£3,695GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more